Literature DB >> 27392947

Metformin discontinuation less than 72 h is suboptimal for F-18 FDG PET/CT interpretation of the bowel.

Suk Hyun Lee1, Soyoung Jin2, Hyo Sang Lee3, Jin-Sook Ryu1, Jong Jin Lee4.   

Abstract

OBJECTIVE: Metformin-induced [F-18] fluorodeoxyglucose (FDG) bowel uptake can hinder positron emission tomography/computed tomography (PET/CT) evaluation of the bowel. This study aimed to investigate the segmental bowel uptake of FDG according to metformin discontinuation times up to 72 h.
METHODS: We retrospectively divided 240 diabetic patients into four groups: metformin discontinuation <24 h (group A; n = 86), 24-48 h (group B; n = 40), 48-72 h (group C; n = 12), and no metformin (control group; n = 102). Segmental FDG bowel uptakes were measured visually (four-point scale) and semi-quantitatively (maximum standardized uptake value).
RESULTS: Compared with the control group, FDG uptake increased significantly from the ileum to the rectosigmoid colon in group A, from the transverse to the rectosigmoid colon in group B, and from the descending colon to the rectosigmoid colon in group C in both visual and semi-quantitative analyses.
CONCLUSIONS: Metformin discontinuation for <72 h is likely suboptimal for PET/CT image interpretation, especially with respect to the distal segments of the colon.

Entities:  

Keywords:  Bowel uptake; Diabetes; FDG PET/CT; Metformin

Mesh:

Substances:

Year:  2016        PMID: 27392947     DOI: 10.1007/s12149-016-1106-7

Source DB:  PubMed          Journal:  Ann Nucl Med        ISSN: 0914-7187            Impact factor:   2.668


  7 in total

1.  The effect of additional acarbose on metformin-associated artificially high 18F-Fluorodeoxyglucose uptake in positron emission tomography/computed tomography.

Authors:  Emre Urhan; Emre Temizer; Zuleyha Karaca; Ummuhan Abdulrezzak; Canan Sehit Kara; Aysa Hacioglu; Kursad Unluhizarci
Journal:  Acta Diabetol       Date:  2022-04-16       Impact factor: 4.280

Review 2.  Effect of metformin on 18F-fluorodeoxyglucose uptake and positron emission tomographic imaging.

Authors:  Xieyi Zhang; Takuo Ogihara; Min Zhu; Dolgormaa Gantumur; Yang Li; Kenta Mizoi; Hiroki Kamioka; Yoshito Tsushima
Journal:  Br J Radiol       Date:  2021-11-16       Impact factor: 3.039

3.  Assessment of incidental focal colorectal uptake by analysis of fluorine-18 fluorodeoxyglucose positron emission tomography parameters.

Authors:  Haejun Lee; Kyung-Hoon Hwang; Kwang An Kwon
Journal:  World J Clin Cases       Date:  2022-06-16       Impact factor: 1.534

4.  Metformin action in the gut-insight provided by [18F]FDG PET imaging.

Authors:  Hitomi Tsuchida; Yasuko Morita; Munenobu Nogami; Wataru Ogawa
Journal:  Diabetol Int       Date:  2021-09-23

5.  Personalised insulin calculator enables safe and effective correction of hyperglycaemia prior to FDG PET/CT.

Authors:  David A Pattison; Lisa L MacFarlane; Jason Callahan; Emma L Kane; Timothy Akhurst; Rodney J Hicks
Journal:  EJNMMI Res       Date:  2019-02-08       Impact factor: 3.138

6.  Mechanisms of metformin action: In and out of the gut.

Authors:  Takahiro Minamii; Munenobu Nogami; Wataru Ogawa
Journal:  J Diabetes Investig       Date:  2018-06-05       Impact factor: 4.232

Review 7.  The utility of pharmacological and radiological interventions to optimize diagnostic information from PET/CT.

Authors:  David Dudoignon; David A Pattison; Damien Legallois; Rodney J Hicks; Nicolas Aide
Journal:  Cancer Imaging       Date:  2020-09-22       Impact factor: 3.909

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.